News Release

HIMSS-IIP Testing Method Approved for Health IT Certification Program

The HIMSS-Immunization Integration Program testing method offers another option for testing health information technology clinical software and electronic health record systems

CHICAGO (October 17, 2017) – Continuing its focus on integrating immunization-related data into the electronic health record and other clinical software systems, the HIMSS Immunization Integration Program (HIMSS-IIP) earned approval from the Office of the National Coordinator for Health Information Technology (ONC) as an alternative testing method for the Health IT Certification program.

The HIMSS-IIP testing method

ONC announced the approval in its Oct. 17 Health IT Buzz blog post. HIMSS “has successfully demonstrated that its testing method, as part of the Immunization Integration Program (HIMSS-IIP), can serve as an alternative to the current National Coordinator-approved method for testing transmissions to immunization registries.”

The approval of the HIMSS-IIP testing method follows the ONC guidelines for an approved and alternative testing option, one where, following an established pathway, industry can submit alternative testing methods for approval. Following that approach, HIMSS-IIP met those requirements and now provides another testing method beyond what was available at the start of the 2015 testing period. In addition, this newly approved testing method relies on the testing tool developed by National Institute of Standards and Technology (NIST).

Background on the HIMSS-IIP program

The HIMSS Immunization Integration Program - conducted in collaboration with ICSA Labs and Chicksaw Health Consulting under a contract with Centers for Disease Control and Prevention (CDC) National Center for Immunization and Respiratory Diseases - is advancing the inclusion of immunization-related capabilities within EHRs and other clinical software by:

• Facilitating agreement on priority immunization-related software capabilities that align with clinical workflows;

• Enabling software developers to voluntarily test and achieve recognition of their products under the HIMSS-IIP; and

• Providing guidance for improving usability of immunization-related software functions.

Integrating immunization-related capabilities within EHRs and other clinical software is expected to improve clinical and patient decision-making by providing more timely access to immunization histories and forecasts and supporting information sharing between EHRs and immunization registries.

The HIMSS-IIP program is the second alternative testing method available; ONC approved the NCQA’s testing method for electronic clinical quality measures in June 2017.

“HIMSS-IIP reached this important milestone for approval of an alternative testing method through a successful public-private partnership between HIMSS, Chickasaw Health, and the CDC," said Thomas M. Leary, MA, CAE, FHIMSS, vice president, government relations, HIMSS North America. “As a collaborative effort, this project relied on the expertise and time of clinicians, publics health organizations, and the health IT industry, who worked together to find ways to align immunization-related workflow with clinical information and EHR systems to ultimately improve care for patients."

 

Learn more about the HIMSS-IIP program and its testing method.

Contact IIPhelp@himss.org for more information.

 

About HIMSS North America

About Chickasaw Health Consulting

Chickasaw Health Consulting, LLC, a rapidly-growing 8(a) small, disadvantaged business, is a subsidiary of Chickasaw Nation Industries, Inc. (CNI), a federally chartered corporation wholly owned by the Chickasaw Nation. CNI’s subsidiaries have a long history of working with the U.S. Department of Health and Human Services and the Centers for Disease Control and Prevention to provide consulting, information technology, and professional staffing services.

 

###

 

Media contact:

Joyce Lofstrom/HIMSS

312-915-9237 jlofstrom@himss.org